It has been researched for its role in regulating lipolysis and inhibiting lipogenesis without significantly affecting blood glucose or insulin levels. Unlike full growth hormone, AOD-9604 does not appear to stimulate IGF-1 production, which may reduce the risk of systemic hormonal effects. It has been studied for its potential impact on body fat reduction, metabolic health, and support of weight management through targeted action on adipose tissue.